Cargando…

The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson’s Disease

Parkinson’s disease (PD) does not manifest clinically until 80 % of striatal dopamine is reduced, thus most neuronal damage takes place before the patient presents clinical symptoms. Therefore, it is important to develop preventive strategies for this disease. In the experimental models of PD, 1-met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calandria, Jorgelina M., Sharp, Michelle W., Bazan, Nicolas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602058/ https://www.ncbi.nlm.nih.gov/pubmed/26047923 http://dx.doi.org/10.1007/s10571-015-0206-6

Ejemplares similares

Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection
por: Asatryan, Aram, et al.
Publicado: (2017)

Neuroprotectin D1 upregulates Iduna expression and provides protection in cellular uncompensated oxidative stress and in experimental ischemic stroke
por: Belayev, Ludmila, et al.
Publicado: (2017)

cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection
por: Calandria, Jorgelina M., et al.
Publicado: (2022)

Ataxin-1 Poly(Q)-induced Proteotoxic Stress and Apoptosis Are Attenuated in Neural Cells by Docosahexaenoic Acid-derived Neuroprotectin D1
por: Calandria, Jorgelina M., et al.
Publicado: (2012)

Correction to: cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection
por: Calandria, Jorgelina M., et al.
Publicado: (2022)

Neuroprotectin D1 Attenuates Laser-induced Choroidal Neovascularization in Mouse
por: Sheets, Kristopher G., et al.
Publicado: (2010)

Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models
por: Zhao, Yuhai, et al.
Publicado: (2011)

Retinal Pigment Epithelium and Photoreceptor Preconditioning Protection Requires Docosanoid Signaling
por: Knott, Eric J., et al.
Publicado: (2017)

Hippocampal Neuro-Networks and Dendritic Spine Perturbations in Epileptogenesis Are Attenuated by Neuroprotectin D1
por: Musto, Alberto E., et al.
Publicado: (2015)

Microglial ramification and redistribution concomitant with the attenuation of choroidal neovascularization by neuroprotectin D1
por: Sheets, Kristopher G., et al.
Publicado: (2013)

Docosanoid signaling modulates corneal nerve regeneration: effect on tear secretion, wound healing, and neuropathic pain
por: Pham, Thang L., et al.
Publicado: (2021)

High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients
por: Archambault, Anne‐Sophie, et al.
Publicado: (2021)

Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window
por: Reid, Madigan M., et al.
Publicado: (2022)

Targeting lipid metabolism in cancer: neuroblastoma
por: Agostini, Massimiliano, et al.
Publicado: (2022)

Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity
por: Shaw, Lynn Calvin, et al.
Publicado: (2018)

Neuroprotectin D1 Protects Against Postoperative Delirium-Like Behavior in Aged Mice
por: Zhou, Ying, et al.
Publicado: (2020)

Corrigendum: Neuroprotectin D1 protects against postoperative delirium-like behavior in aged mice
por: Zhou, Ying, et al.
Publicado: (2022)

Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners
por: Archambault, Anne-Sophie, et al.
Publicado: (2022)

Elovanoid-N32 or RvD6-isomer decrease ACE2 and binding of S protein RBD after injury or INFγ in the eye
por: Pham, Thang L., et al.
Publicado: (2020)

Targeting Phospholipase D Pharmacologically Prevents Phagocytic Function Loss of Retinal Pigment Epithelium Cells Exposed to High Glucose Levels
por: Bermúdez, Vicente, et al.
Publicado: (2022)

ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea
por: Pham, Thang L., et al.
Publicado: (2021)

Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival
por: Rice, Dennis S., et al.
Publicado: (2015)

Corrigendum: Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival
por: Rice, Dennis S., et al.
Publicado: (2015)

Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells
por: Calandria, Jorgelina M., et al.
Publicado: (2021)

New Retinal Pigment Epithelial Cell Model to Unravel Neuroprotection Sensors of Neurodegeneration in Retinal Disease
por: Asatryan, Aram, et al.
Publicado: (2022)

NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival
por: Calandria, J M, et al.
Publicado: (2015)

Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology
por: Romeo, Stefania, et al.
Publicado: (2013)

An Automated Cell Detection Method for TH-positive Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease Using Convolutional Neural Networks
por: Kim, Doyun, et al.
Publicado: (2023)

Optogenetically induced cellular habituation in non-neuronal cells
por: Bonzanni, Mattia, et al.
Publicado: (2020)

Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson’s Disease
por: Yin, Yue, et al.
Publicado: (2012)

Adult Hippocampal Neurogenesis in Parkinson's Disease: Impact on Neuronal Survival and Plasticity
por: Regensburger, Martin, et al.
Publicado: (2014)

The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease
por: Benskey, Matthew J., et al.
Publicado: (2016)

Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease
por: Morales-Garcia, Jose A., et al.
Publicado: (2011)

Tilianin attenuates MPP(+)-induced oxidative stress and apoptosis of dopaminergic neurons in a cellular model of Parkinson's disease
por: Li, Jie, et al.
Publicado: (2022)

Establishment of a Survival and Toxic Cellular Model for Parkinson’s Disease from Chicken Mesencephalon
por: Tolosa, Amparo, et al.
Publicado: (2012)

Urate and Its Transgenic Depletion Modulate Neuronal Vulnerability in a Cellular Model of Parkinson's Disease
por: Cipriani, Sara, et al.
Publicado: (2012)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease
por: Zhao, Yi, et al.
Publicado: (2018)

Products of the Parkinson's disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival
por: Toyoda, Yusuke, et al.
Publicado: (2014)

Cellular and Synaptic Dysfunctions in Parkinson’s Disease: Stepping Out of the Striatum
por: Mallet, Nicolas, et al.
Publicado: (2019)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons
por: Zambon, Federico, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4nqacaolu0lmr0jj684nlhdm90